Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Methods of extraction of optical properties from diffuse reflectance measurements of ex-vivo human colon tissue using thin film silicon photodetector arrays.

LaRiviere B, Ferguson NL, Garman KS, Fisher DA, Jokerst NM.

Biomed Opt Express. 2019 Oct 11;10(11):5703-5715. doi: 10.1364/BOE.10.005703. eCollection 2019 Nov 1.

2.

Pathogenesis and Cells of Origin of Barrett's Esophagus.

Que J, Garman KS, Souza RF, Spechler SJ.

Gastroenterology. 2019 Aug;157(2):349-364.e1. doi: 10.1053/j.gastro.2019.03.072. Epub 2019 May 10. Review.

PMID:
31082367
3.

Inconsistencies in Colonic Tattooing Practice: Differences in Reported and Actual Practices at a Tertiary Medical Center.

Spaete JP, Zheng J, Chow SC, Burbridge RA, Garman KS.

South Med J. 2019 Apr;112(4):222-227. doi: 10.14423/SMJ.0000000000000964.

4.

Barrett's esophagus and esophageal cancer: Links to microbes and the microbiome.

Ajayi TA, Cantrell S, Spann A, Garman KS.

PLoS Pathog. 2018 Dec 20;14(12):e1007384. doi: 10.1371/journal.ppat.1007384. eCollection 2018 Dec. No abstract available.

5.

Helicobacter pylori-associated peptic ulcer disease: A retrospective analysis of post-treatment testing practices.

Feder R, Posner S, Qin Y, Zheng J, Chow SC, Garman KS.

Helicobacter. 2018 Dec;23(6):e12540. doi: 10.1111/hel.12540. Epub 2018 Sep 23.

PMID:
30246287
6.

Esophageal submucosal glands as a potential source of subsquamous intestinal metaplasia in Barrett's esophagus.

Garman KS, McCall SJ.

Gastrointest Endosc. 2018 Jul;88(1):200-201. doi: 10.1016/j.gie.2018.01.027. No abstract available.

PMID:
29935616
7.

Spatially resolved diffuse reflectance spectroscopy endoscopic sensing with custom Si photodetectors.

Lariviere B, Garman KS, Ferguson NL, Fisher DA, Jokerst NM.

Biomed Opt Express. 2018 Feb 15;9(3):1164-1176. doi: 10.1364/BOE.9.001164. eCollection 2018 Mar 1.

8.

Porcine Esophageal Submucosal Gland Culture Model Shows Capacity for Proliferation and Differentiation.

von Furstenberg RJ, Li J, Stolarchuk C, Feder R, Campbell A, Kruger L, Gonzalez LM, Blikslager AT, Cardona DM, McCall SJ, Henning SJ, Garman KS.

Cell Mol Gastroenterol Hepatol. 2017 Aug 4;4(3):385-404. doi: 10.1016/j.jcmgh.2017.07.005. eCollection 2017 Nov.

9.

Origin of Barrett's Epithelium: Esophageal Submucosal Glands.

Garman KS.

Cell Mol Gastroenterol Hepatol. 2017 Mar 6;4(1):153-156. doi: 10.1016/j.jcmgh.2017.01.016. eCollection 2017 Jul.

10.

Ductular and proliferative response of esophageal submucosal glands in a porcine model of esophageal injury and repair.

Kr├╝ger L, Gonzalez LM, Pridgen TA, McCall SJ, von Furstenberg RJ, Harnden I, Carnighan GE, Cox AM, Blikslager AT, Garman KS.

Am J Physiol Gastrointest Liver Physiol. 2017 Sep 1;313(3):G180-G191. doi: 10.1152/ajpgi.00036.2017. Epub 2017 Jun 1.

11.

Ductal metaplasia in oesophageal submucosal glands is associated with inflammation and oesophageal adenocarcinoma.

Garman KS, Kruger L, Thomas S, Swiderska-Syn M, Moser BK, Diehl AM, McCall SJ.

Histopathology. 2015 Dec;67(6):771-82. doi: 10.1111/his.12707. Epub 2015 Jun 4.

12.

Pleiotrophin regulates the ductular reaction by controlling the migration of cells in liver progenitor niches.

Michelotti GA, Tucker A, Swiderska-Syn M, Machado MV, Choi SS, Kruger L, Soderblom E, Thompson JW, Mayer-Salman M, Himburg HA, Moylan CA, Guy CD, Garman KS, Premont RT, Chute JP, Diehl AM.

Gut. 2016 Apr;65(4):683-92. doi: 10.1136/gutjnl-2014-308176. Epub 2015 Jan 16.

13.

Cellular origins and molecular mechanisms of Barrett's esophagus and esophageal adenocarcinoma.

Fang Y, Chen X, Bajpai M, Verma A, Das KM, Souza RF, Garman KS, Donohoe CL, O'Farrell NJ, Reynolds JV, Dvorak K.

Ann N Y Acad Sci. 2013 Oct;1300:187-199. doi: 10.1111/nyas.12249. Review.

PMID:
24117642
14.

MicroRNA expression differentiates squamous epithelium from Barrett's esophagus and esophageal cancer.

Garman KS, Owzar K, Hauser ER, Westfall K, Anderson BR, Souza RF, Diehl AM, Provenzale D, Shaheen NJ.

Dig Dis Sci. 2013 Nov;58(11):3178-88. doi: 10.1007/s10620-013-2806-7. Epub 2013 Aug 8.

15.

Feasibility, safety, acceptability, and yield of office-based, screening transnasal esophagoscopy (with video).

Peery AF, Hoppo T, Garman KS, Dellon ES, Daugherty N, Bream S, Sanz AF, Davison J, Spacek M, Connors D, Faulx AL, Chak A, Luketich JD, Shaheen NJ, Jobe BA; Barrett's Esophagus Risk Consortium.

Gastrointest Endosc. 2012 May;75(5):945-953.e2. doi: 10.1016/j.gie.2012.01.021. Epub 2012 Mar 16.

16.

Review: Experimental models for Barrett's esophagus and esophageal adenocarcinoma.

Garman KS, Orlando RC, Chen X.

Am J Physiol Gastrointest Liver Physiol. 2012 Jun 1;302(11):G1231-43. doi: 10.1152/ajpgi.00509.2011. Epub 2012 Mar 15. Review.

17.

Retraction: Acharya CR, et al. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer. JAMA. 2008;299(13):1574-1587.

Acharya CR, Hsu DS, Anders CK, Anguiano A, Salter KH, Walters KS, Redman RC, Tuchman SA, Moylan CA, Mukherjee S, Barry WT, Dressman HK, Ginsburg GS, Marcom KP, Garman KS, Lyman GH, Nevins JR, Potti A.

JAMA. 2012 Feb 1;307(5):453. doi: 10.1001/jama.2012.2. Epub 2012 Jan 6. No abstract available.

PMID:
22228686
18.

Retraction for Garman et al: A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities.

Garman KS, Acharya CR, Edelman E, Grade M, Gaedcke J, Sud S, Barry W, Diehl AM, Provenzale D, Ginsburg GS, Ghadimi BM, Ried T, Nevins JR, Mukherjee S, Hsu D, Potti A.

Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17569. doi: 10.1073/pnas.1115170108. Epub 2011 Oct 3. No abstract available.

19.

Ablative therapies for Barrett's esophagus.

Garman KS, Shaheen NJ.

Curr Gastroenterol Rep. 2011 Jun;13(3):226-39. doi: 10.1007/s11894-011-0182-z. Review.

20.
21.

A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities.

Garman KS, Acharya CR, Edelman E, Grade M, Gaedcke J, Sud S, Barry W, Diehl AM, Provenzale D, Ginsburg GS, Ghadimi BM, Ried T, Nevins JR, Mukherjee S, Hsu D, Potti A.

Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19432-7. doi: 10.1073/pnas.0806674105. Epub 2008 Dec 2. Erratum in: Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6878. Retraction in: Garman KS, Acharya CR, Edelman E, Grade M, Gaedcke J, Sud S, Barry W, Diehl AM, Provenzale D, Ginsburg GS, Ghadimi BM, Ried T, Nevins JR, Mukherjee S, Hsu D, Potti A. Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17569.

22.

Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer.

Acharya CR, Hsu DS, Anders CK, Anguiano A, Salter KH, Walters KS, Redman RC, Tuchman SA, Moylan CA, Mukherjee S, Barry WT, Dressman HK, Ginsburg GS, Marcom KP, Garman KS, Lyman GH, Nevins JR, Potti A.

JAMA. 2008 Apr 2;299(13):1574-87. doi: 10.1001/jama.299.13.1574. Retraction in: Acharya CR, Hsu DS, Anders CK, Anguiano A, Salter KH, Walters KS, Redman RC, Tuchman SA, Moylan CA, Mukherjee S, Barry WT, Dressman HK, Ginsburg GS, Marcom KP, Garman KS, Lyman GH, Nevins JR, Potti A. JAMA. 2012 Feb 1;307(5):453.

PMID:
18387932
23.

An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer.

Salter KH, Acharya CR, Walters KS, Redman R, Anguiano A, Garman KS, Anders CK, Mukherjee S, Dressman HK, Barry WT, Marcom KP, Olson J, Nevins JR, Potti A.

PLoS One. 2008 Apr 2;3(4):e1908. doi: 10.1371/journal.pone.0001908. Retraction in: PLoS One. 2011;6(9). doi: 10.1371/annotation/8f94e479-4161-43a0-a28c-4c0460bb89a4.

24.

Genomic strategies for personalized cancer therapy.

Garman KS, Nevins JR, Potti A.

Hum Mol Genet. 2007 Oct 15;16 Spec No. 2:R226-32. Review.

PMID:
17911165
25.

Clinical diagnostic reasoning.

Echols MR, Garman KS, Lyles KW.

N Engl J Med. 2007 Mar 22;356(12):1272; author reply 1273-4. No abstract available.

PMID:
17380583
26.

Colorectal cancer screening, comorbidity, and follow-up in elderly patients.

Garman KS, Jeffreys A, Coffman C, Fisher DA.

Am J Med Sci. 2006 Oct;332(4):159-63.

PMID:
17031239
27.

Apolipoprotein E epsilon4 allele increases risk for psychotic symptoms in Alzheimer's disease.

Zdanys KF, Kleiman TG, MacAvoy MG, Black BT, Rightmer TE, Grey M, Garman KS, Tampi RR, Gelernter J, van Dyck CH.

Neuropsychopharmacology. 2007 Jan;32(1):171-9. Epub 2006 Jul 12.

28.
29.

Function in elderly cancer survivors depends on comorbidities.

Garman KS, Pieper CF, Seo P, Cohen HJ.

J Gerontol A Biol Sci Med Sci. 2003 Dec;58(12):M1119-24.

PMID:
14684709
30.

Functional status and the elderly cancer patient.

Garman KS, Cohen HJ.

Crit Rev Oncol Hematol. 2002 Sep;43(3):191-208. Review.

PMID:
12270776

Supplemental Content

Loading ...
Support Center